
Parabilis Medicines
Developer of cell-penetrating mini proteins (CPMPs) designed to target cancer-causing proteins inside cancer cells and neutralize them. The company's mini proteins (CPMPs) are a broad new class of med...
Valuation
$400M
Latest known
Share Price
N/A
Total Raised
$507M
Last Round
N/A